Market revenue in 2023 | USD 540.7 million |
Market revenue in 2030 | USD 1,016.1 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32% in 2023. Horizon Databook has segmented the Mexico orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
Key factors anticipated to drive the market in the country are growing prevalence of osteoarthritis and osteoporosis in the country. According to an article published in an online journal in 2019, Mexico was one of the four major LATAM countries to report large number of fracture cases due to osteoporosis.
According to an article published in PubMed in 2018, the number if hip fractures in Mexican women suffering from osteoporosis is increasing. The study estimated that only 73% of the women suffering from the condition can resume walking after hip replacement or reconstruction surgeries.
Hence, as the prevalence of osteoporosis among Mexican women is increasing, the number of replacement and reconstruction surgeries is also increasing. This is further estimated to drive the market over the forecast period. Furthermore, increasing cases of sport-related injuries in the country is also anticipated to drive the market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into Mexico orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account